Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Don’t Ignore Under-The-Radar Curtis Macnguyen’s Top New Picks

Page 1 of 2

Ivory Investment Management L.P. is a Los Angeles-based research-intensive hedge fund firm founded by Curtis Macnguyen in 1998. The hedge fund currently employs one long and two long/short investment strategies. Initially, the fundamental value-based investment firm was financed with seed capital from outside investors amounting to $10 million and it has managed to deliver quite exceptional returns despite focusing on this relatively “old-fashioned” investment approach. The flagship fund of Ivory Investment Management has delivered a cumulative return of 346% since its inception, more than doubling the 139% cumulative return delivered by the Standard & Poor’s 500 Index during the same period. Therefore, the fund has generated an annualized return of as much as 9.7% since its establishment, which represents an attractive return considering the economic turmoil experienced throughout the last decade. As shown in the fund’s latest 13F filing, the value of its public equity portfolio stands at $4.23 billion. In the following article we will list and discuss the top new picks of Curtis Macnguyen, which include the following companies: Western Digital Corporation (NASDAQ:WDC), St. Jude Medical Inc. (NYSE:STJ), Bank of America Corporation (NYSE:BAC) and Delta Air Lines Inc. (NYSE:DAL).

Curtis Macnguyen

Ivory Investment Management is just one of more than 700 hedge funds that we have in our database, whose equity portfolios we collate quarterly as part of our small-cap strategy. Even though most smaller investors believe that tracking 13F filings is a fruitless endeavor because they are filed with a delay of a maximum of 45 days after the end of a calendar quarter, the results of our research prove that is not the case. To be on the safe side, we used a delay of 60 days in our backtests that involved the 13F filings of funds between 1999 and 2012 and we still managed to gain an annual alpha in the double digits. Moreover, since the official launch of our strategy in August 2012, our small-cap strategy has obtained returns of more than 142%, beating the S&P 500 Total Return Index by greater than 83 percentage points (see the details).

That latest 13F filing reveals that Ivory Investment Management has taken a long position in Western Digital Corporation (NASDAQ:WDC). Macnguyen purchased a stake of 1.56 million shares worth $141.83 million during the first quarter, which, considering the fact that shares of Western Digital have plummeted by 17% year-to-date, might represent that it’s a really cheap buying opportunity for bottom-fishing investors at the moment. This idea is also supported by the research team at Goldman Sachs, which recently upgraded the stock to a “Buy” rating from a “Neutral” one. At the same time, the reputable investment banking firm also raised the stock’s price target to $122 from $106, which yields a potential 33% upside for investors. Within our database, Ken Griffin’s Citadel Investment Group is the largest investor in Western Digital Corporation (NASDAQ:WDC), owning 3.07 million shares valued at $279.41 million.

Ivory Investment Management also acquired a 1.73 million share-stake in St. Jude Medical Inc. (NYSE:STJ), with the stake valued at $113.29 million. Despite the fact that the stock is already up 13% in 2015, it might keep rising in the upcoming months as the company has been constantly introducing new revolutions and products to the market. On June 4, the company announced the CE Mark approval for the St. Jude Medical Invisible Trial System in Europe, which is an app-based and wireless neuromodulation programming system. Therefore, the newly-launched system provides a secure, safe and wireless experience when patients trial spinal cord stimulation for the remedy of chronic pain. This is only one of the high number of launches and developments St. Jude Medical has been announcing lately, so the company and the stock have more room to grow in the future. David Stemerman’s Conatus Capital Management is among the largest shareholders in St. Jude Medical Inc. (NYSE:STJ) from the hedge funds we track, owning 1.32 million shares, trailing only Macnguyen.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!